logo
OF SPECIAL INTEREST
Long-awaited patient safety bill enacted
New heart-failure therapy takes race into account
Infectious diseases expected to capture headlines, attention in months ahead
Drug regulatory process is focused on safety, officials claim
Pharmacist intervention when interacting drugs are prescribed despite alerts
Clinical pharmacists
Pharmacist position monitoring health-system employees' drug plan
Specialized pediatric residency programs
Pharmacists as laboratorians
Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients
Documenting drug-related problems with personal digital assistants in a multisite health system
Assessing the clinical significance of drug interactions with fluorouracil in patients with colorectal cancer
Documentation of pharmacist interventions in the emergency department
Relationship between number, timing, and type of pharmacist interventions and patient outcomes
Devices for ambulatory and home monitoring of blood pressure, lipids, coagulation, and weight management, part 1
Safe chemotherapy administration
Pharmacy Residency Training in the Future
Actions of the ASHP Board of Directors—meeting of June 11–14, 2005
Administering pharmaceuticals to latex-allergic patients from vials containing natural rubber latex closures
Pharmacists, pharmaceutical manufacturers, and conflicts of interest
Medication use in the emergency department
The Mold in Dr. Florey's Coat
Pain and Profits
Powerful Medicines